Year: 2015
Type: letter
Abstract: We appreciate the comments by Pagliaro et al 1 regarding the management options for clinical stage I testicular cancer (CSI-TC).An extensive and heated debate has recently been going on over the best management option for CSI-TC, with the experts for the most part being split into the "surveillance-ists" and the "chemotherapists."Pagliario et al make their case in favor of adjuvant chemotherapy,
Source: Journal of Clinical Oncology
Language: French
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: BC Cancer Agency
OpenAlex ID: W2096291457